Robeco Institutional Asset Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.85M Buy
131,331
+32,536
+33% +$2.17M 0.01% 461
2026
Q1
$6.2M Sell
98,795
-5,377
-5% -$374K 0.01% 513
2025
Q4
$6.91M Sell
104,172
-85,745
-45% -$5.54M 0.01% 502
2025
Q3
$12.8M Sell
189,917
-14,640
-7% -$1.16M 0.02% 408
2025
Q2
$17.9M Sell
204,557
-31,727
-13% -$2.49M 0.03% 371
2025
Q1
$16.1M Buy
236,284
+213,483
+936% +$17.4M 0.03% 362
2024
Q4
$1.77M Sell
22,801
-259
-1% -$19.2K ﹤0.01% 719
2024
Q3
$1.55M Sell
23,060
-1,003,493
-98% -$82.4M ﹤0.01% 744
2024
Q2
$116M Buy
1,026,553
+858,285
+510% +$109M 0.25% 89
2024
Q1
$23.3M Buy
168,268
+13,667
+9% +$1.72M 0.05% 318
2023
Q4
$19.2M Sell
154,601
-78,611
-34% -$8.03M 0.05% 333
2023
Q3
$21.8M Sell
233,212
-72,921
-24% -$8.22M 0.06% 302
2023
Q2
$39.3M Buy
306,133
+7,074
+2% +$856K 0.1% 205
2023
Q1
$34.7M Buy
299,059
+21,863
+8% +$2.45M 0.09% 228
2022
Q4
$31.4M Sell
277,196
-92,405
-25% -$10.1M 0.09% 230
2022
Q3
$29.8M Buy
369,601
+9,970
+3% +$844K 0.1% 202
2022
Q2
$26.8M Buy
359,631
+11,531
+3% +$1.05M 0.08% 222
2022
Q1
$44.5M Buy
348,100
+17,680
+5% +$1.93M 0.1% 208
2021
Q4
$44.4M Buy
330,420
+69,132
+26% +$9.93M 0.09% 234
2021
Q3
$35.7M Buy
261,288
+14,924
+6% +$1.88M 0.08% 263
2021
Q2
$26.3M Buy
246,364
+35,160
+17% +$3.38M 0.06% 313
2021
Q1
$19M Sell
211,204
-71,480
-25% -$6.71M 0.05% 360
2020
Q4
$26.1M Sell
282,684
-117,796
-29% -$10.5M 0.07% 287
2020
Q3
$41.3M Sell
400,480
-13,304
-3% -$1.39M 0.13% 184
2020
Q2
$41.9M Sell
413,784
-132,416
-24% -$11.8M 0.14% 176
2020
Q1
$36.8M Buy
546,200
+3,916
+0.7% +$244K 0.15% 183
2019
Q4
$29.7M Sell
542,284
-170,356
-24% -$8.08M 0.09% 268
2019
Q3
$26.6M Sell
712,640
-152,216
-18% -$5.91M 0.09% 274
2019
Q2
$32.4M Buy
864,856
+216,348
+33% +$6.8M 0.11% 240
2019
Q1
$19.3M Buy
648,508
+157,200
+32% +$5.52M 0.07% 352
2018
Q4
$14.7M Buy
+491,308
New +$15.6M 0.07% 344

Other funds holding DXCM

Robeco Institutional Asset Management's DXCM Position: Q2 2026 in Review

Robeco Institutional Asset Management increased its DexCom (DXCM) stake by 33% in Q2 2026, buying an estimated $2.17M and bringing the position to 131,331 shares worth $8.85M. The position accounts for 0.01% of the portfolio, ranked #461.

Robeco Institutional Asset Management first reported a position in DXCM in Q4 2018 and has held it in 31 quarters since. The position peaked at $116M in Q2 2024. 496 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Robeco Institutional Asset Management held 131,331 shares of DexCom worth $8.85M as of Q2 2026.
  • Robeco Institutional Asset Management bought 32,536 DexCom shares in Q2 2026, an estimated $2.17M.
  • DexCom made up 0.01% of Robeco Institutional Asset Management's portfolio in Q2 2026, its #461 holding.
  • Robeco Institutional Asset Management first reported a position in DexCom in Q4 2018 and has held it in 31 quarters since.
  • Robeco Institutional Asset Management's DexCom position peaked at $116M in Q2 2024.
  • 496 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Robeco Institutional Asset Management's 13F filing for Q2 2026, filed 21 Jul 2026.